What level of thyroglobulin predicts cancer recurrence?

Australian study suggests more patients are at low risk than current advice suggests

Doctors could use a cut-off level of 2ng/mL for stimulated thyroglobulin to determine which patients with papillary thyroid cancer are more likely to have post-op recurrence, Australian researchers say.